Active — Not RecruitingNot Applicable

Feasibility of Molecular Biology in Pancreatic Cyst Tumors

France93 participantsStarted 2017-01

Plain-language summary

The main objective of the study is to compare the diagnostic accuracy of intra-cystic fluid DNA molecular analysis to standard diagnostics. The secondary objective of the study is to evaluate the feasibility of intra-cystic fluid DNA molecular analysis.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patient older than 18 years of age, male or female * Cystic tumor of the pancreas requiring a puncture under endoscopic control to determine the etiologic diagnosis and gravity. Exclusion Criteria: * Doubts regarding the etiological diagnosis of the pancreatic cyst * Contraindications for the realization of a high digestive endoscopy * Haemorrhagic disorder, haemostasis and coagulation disorder (TP \<60%, TCa\> 40 sec and platelets \<60000 / mm3). * AVK, AOD and AAP cannot be stopped

What they're measuring

Comparison between gene mutations found into the pancreatic cystic tumor fluid to gene mutations found into tissue specimen

Timeframe: 10 days

Trial details

NCT IDNCT03305146

SponsorHospital St. Joseph, Marseille, France

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2017-12

View on ClinicalTrials.gov More Pancreatic Cyst trials